cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Rafael Holdings Inc Class B
4 own
15 watching
Current Price
$2.09
$-0.03
(-1.42%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
51.15M
52-Week High
52-Week High
4.06
52-Week Low
52-Week Low
1.6
Average Volume
Average Volume
0.04M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization51.15M
icon52-Week High4.06
icon52-Week Low1.6
iconAverage Volume0.04M
iconDividend Yield--
iconP/E Ratio--
What does the Rafael Holdings Inc Class B do?
Rafael Holdings, Inc. holds interests in clinical and early stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. The company operates in two segments, Pharmaceuticals and Real Estate. It engages in the leasing of a commercial office building, as well as an associated 800-car public garage; and development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company s lead drug candidate is CPI-613 (devimistat), which is being evaluated in various clinical studies, including two Phase III registrational clinical trials for the treatment of metastatic pancreatic cancer and r/r acute myeloid leukemia. Rafael Holdings, Inc. is headquartered in Newark, New Jersey.
Read More
How much money does Rafael Holdings Inc Class B make?
News & Events about Rafael Holdings Inc Class B.
Globe Newswire
7 months ago
Cranbury, N.J., June 16, 2022 (GLOBE NEWSWIRE) -- Cornerstone Pharmaceuticals, Inc.(Cornerstone or the Company), a company focused on rare cancer therapeutics and formerly known as Rafael Pharmaceuticals, today announced a publication on preclinical data supporting CPI-613 (devimistat) targeting ...
Globe Newswire
8 months ago
Cranbury, NJ, May 24, 2022 (GLOBE NEWSWIRE) -- Cornerstone Pharmaceuticals, Inc. (Cornerstone or the Company), a company focused on rare cancer therapeutics and formerly known as Rafael Pharmaceuticals, today announced that the European Medicines Agency (EMA) has granted orphan drug designation to ...
Globe Newswire
8 months ago
Company name change reflects mission to address significant unmet needs in rare cancer therapeutics, returning to company rootsCranbury, NJ, May 19, 2022 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc. (Rafael or the Company), a company focused on the development of rare cancer therapeutics, today ...
PR Newswire
10 months ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rafael Holdings, Inc. - RFL SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rafael Holdings, Inc. - RFL PR Newswire NEW YORK, March 26, 2022 NEW YORK, March 26, 2022 /PRNewswire...
PR Newswire
10 months ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rafael Holdings, Inc. - RFL SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rafael Holdings, Inc. - RFL PR Newswire NEW YORK, March 16, 2022 NEW YORK, March 16, 2022 /PRNewswire...
Frequently Asked Questions
Frequently Asked Questions
What is Rafael Holdings Inc Class B share price today?
plus_minus_icon
Can Indians buy Rafael Holdings Inc Class B shares?
plus_minus_icon
How can I buy Rafael Holdings Inc Class B shares from India?
plus_minus_icon
Can Fractional shares of Rafael Holdings Inc Class B be purchased?
plus_minus_icon
What are the documents required to start investing in Rafael Holdings Inc Class B stocks?
plus_minus_icon
What is today’s traded volume of Rafael Holdings Inc Class B?
plus_minus_icon
What is today’s market capitalisation of Rafael Holdings Inc Class B?
plus_minus_icon
What is the 52-Week High and Low Range of Rafael Holdings Inc Class B?
plus_minus_icon
What percentage is Rafael Holdings Inc Class B down from its 52-Week High?
plus_minus_icon
What percentage is Rafael Holdings Inc Class B up from its 52-Week Low?
plus_minus_icon
Current Price
$2.09
$-0.03
(-1.42%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00